Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record provides details of Hoffmann-La Roche’s completed study comparing subcutaneous and intravenous atezolizumab for previously treated locally advanced or metastatic non-small cell lung cancer, including study methods, participant criteria, locations, outcome measures, and related publications and documents.
    Difference
    95%
    Check dated 2026-11-08T14:34:34.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T15:45:21.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition notice and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T17:16:13.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision label updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:12:01.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T22:13:37.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating restricted access to the page. Visible additions include the 403 text and a Home link, while the previous detailed study content and navigation elements have been removed.
    Difference
    19%
    Check dated 2026-09-20T19:45:03.000Z thumbnail image

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.